Lipum AB (publ) (STO:LIPUM)

Sweden flag Sweden · Delayed Price · Currency is SEK
14.55
+0.25 (1.75%)
Feb 26, 2026, 4:39 PM CET
Market Cap303.34M
Revenue (ttm)1.93M
Net Income-71.53M
EPS-3.37
Shares Out21.21M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume28,231
Average Volume12,568
Open14.40
Previous Close14.30
Day's Range14.40 - 14.60
52-Week Range8.56 - 21.20
Beta0.25
RSI64.24
Earnings DateFeb 25, 2026

About Lipum AB

Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. The company develops SOL-116, a humanized antibody that is in late preclinical phase for the treatment of juvenile idiopathic arthritis and rheumatoid arthritis diseases. It has a collaboration with NorthXBiologies for production of SOL-116 setatt; and a collaboration with the Karolinska Institute to explore the role of bile salt-stimulated lipase in the immune system in general and in rheumatoid arthr... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 5
Stock Exchange Nasdaq Stockholm
Ticker Symbol LIPUM
Full Company Profile

Financial Performance

Financial Statements